LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $332,482,107 | -13.6% | 7,506,934 | +9.4% | 4.40% | -10.2% |
| Q1 2024 | $384,838,931 | +2.1% | 6,861,097 | +9.5% | 4.90% | -16.8% |
| Q4 2023 | $376,947,420 | -10.4% | 6,264,707 | 0.0% | 5.89% | -28.9% |
| Q3 2023 | $420,800,369 | -2.7% | 6,264,707 | 0.0% | 8.28% | +1.5% |
| Q2 2023 | $432,452,724 | +268.1% | 6,264,707 | +157.1% | 8.16% | +207.1% |
| Q1 2023 | $117,474,673 | -3.4% | 2,436,223 | 0.0% | 2.66% | +7.8% |
| Q4 2022 | $121,616,252 | +27.5% | 2,436,223 | +4.2% | 2.47% | +21.2% |
| Q3 2022 | $95,415,000 | +137.8% | 2,338,610 | +139.2% | 2.04% | +216.1% |
| Q2 2021 | $40,126,000 | -40.8% | 977,503 | -59.4% | 0.64% | -32.1% |
| Q4 2020 | $67,818,000 | -8.8% | 2,408,292 | 0.0% | 0.95% | -30.3% |
| Q3 2020 | $74,344,000 | -29.6% | 2,408,292 | -3.0% | 1.36% | -33.9% |
| Q2 2020 | $105,631,000 | – | 2,481,942 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |